Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Raya Therapeutic announces early-stage R&D collaboration with argenx 2023-07-12 19:07
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division 2023-07-12 18:46
Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation 2023-07-12 13:38
Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone. 2023-07-12 10:32
Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism 2023-07-12 10:00
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET® 2023-07-12 07:12
Doer Biologics Announces License Agreement with BioNTech 2023-07-11 11:49
Race executes global license agreement with City of Hope to access FTO IP 2023-07-11 07:30
Race executes global license agreement with City of Hope to access FTO IP 2023-07-10 19:30
Rx-360 Expands Trademark Portfolio to Japan 2023-07-10 18:00
Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking Medicine is Set to Revolutionize Healthcare with a 4-Day Hackathon 2023-07-10 15:19
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors 2023-07-10 10:24
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services 2023-07-07 21:00
280 Bio receives IND approval from the FDA for YL-17231 2023-07-07 20:00
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years 2023-07-07 19:43
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001) 2023-07-07 15:52
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs 2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
CARING PHARMACY CELEBRATES UNIFIED CARING MEMBERSHIP PROGRAMME WITH GEORGETOWN PHARMACY AND WELLINGS PHARMACY 2023-07-06 18:00
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
1 54 55 56 57 58 375